Physician lesson

Chemotherapy extravasation: prevention and management

Vesicant drugs, immediate action, dexrazoxane, DMSO and hyaluronidase

Updated: 28 October 20261 min read2 references

Key points

  • If extravasation is suspected: stop the infusion immediately, do not remove the cannula, and aspirate as much of the drug as possible [1].
  • Anthracyclines: cold and IV dexrazoxane within 6 hours [1, 2].
  • Vinca alkaloids: warmth and hyaluronidase, not cold [1].
  • Give vesicants through a central catheter or a large, healthy forearm vein.

Drug categories

Risk of tissue damage [1]
GroupExamples
Vesicant (DNA-binding)Doxorubicin, epirubicin, daunorubicin, idarubicin, mitomycin, dactinomycin, mechlorethamine
Vesicant (non-DNA-binding)Vincristine, vinblastine, vinorelbine, paclitaxel, docetaxel
IrritantOxaliplatin, cisplatin, carboplatin, etoposide, bendamustine, irinotecan
Non-vesicantMethotrexate, cytarabine, gemcitabine, fluorouracil, monoclonal antibodies

Action

  1. 1

    Immediately

    Stop the infusion, aspirate the drug through the cannula, then remove it; mark the area and photograph it; elevate the limb [1].

  2. 2

    Anthracyclines

    Cold pack for 15 to 20 minutes several times a day; IV dexrazoxane within 6 hours: 1000 mg/m² on day 1, 1000 on day 2 and 500 on day 3 (in the other limb) [2]. Topical DMSO is an alternative, but not together with dexrazoxane [1].

  3. 3

    Vinca alkaloids and taxanes

    Warm compresses and subcutaneous hyaluronidase around the area [1].

  4. 4

    Follow-up

    Assess on days 1 and 7 and later; with persistent pain, blistering or necrosis, seek plastic surgery advice [1].

References

2 references
Show all referencesClose the reference list

Numbers in the text, such as [1], refer to these sources. Sources with a “Study card” button are summarised in the site’s evidence library.

  1. 1
    Management of chemotherapy extravasation: ESMO-EONS Clinical Practice GuidelinesPérez Fidalgo JA, García Fabregat L, Cervantes A, et al · Ann Oncol · 2012;23 Suppl 7:vii167-73
    DOIPubMed Back to text: 1 2 3 4 5 6 7 8
  2. 2
    Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studiesMouridsen HT, Langer SW, Buter J, et al · Ann Oncol · 2007;18:546-50
    DOIPubMed Back to text: 1 2

This page is based on reputable scientific sources and was last updated on 28 October 2026. The content of this website is for educational and informational purposes only and does not replace consultation, diagnosis or treatment by a specialist physician. Consult your treating physician about any treatment decision.